Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Immunomodulatory and Health Improving Function of a Chinese Medicine Nutritional Supplement Cs4 on Immunity-related Disorders in the Post-COVID Era

NCT06054438 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT06054438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06054438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Immunomodulatory and Health Improving Function of a Chinese Medicine Nutritional Supplement Cs4 on Immunity-related Disorders in the Post-COVID Era
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Completed
Start date
April 17, 2023
Completion date
March 31, 2024
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid